logo
logo
Sign in

Home Infusion Therapy Market Size, Growth Opportunities, Revenue Share Analysis, and Forecast To 2026

avatar
jhon tanison
Home Infusion Therapy Market Size, Growth Opportunities, Revenue Share Analysis, and Forecast To 2026

 

Ageing demographics, rapid technological developments, increasing adoption of home infusion therapies, favourable government policies and regulations are are key factors contributing to high CAGR of Home infusion therapy during forecast period.

Market Size – USD 22.03 Billion in 2018, Market Growth - CAGR of 7.2%, Market Trends – Product launches and research for advanced Home infusion therapy

According to current analysis of Reports and Data, the global Home Infusion Therapy Market was valued at USD 22.03 billion in 2018 and is expected to reach USD 38.41 billion by the year 2026, at a CAGR of 7.2%. Infusion therapy involves the administration of drugs intravenously. It is prescribed when a patient’s condition is much severe and cannot be treated effectively by oral medications. Receiving this therapy in homecare settings rather than hospitals is referred to as home infusion therapy. Home infusion therapies are very cost-effective, and technological advancements have facilitated safe and effective administration of infusion therapies at home. The advantage infusion offers is that it helps deliver a precise dose of the drug quickly and efficiently, and in a well-controlled manner throughout the body. It is also used for irritating solutions; those can cause pain and even damage tissues if administered by subcutaneous or intramuscular injection.

Moving care into the home is a very important step of change in healthcare. The approach is patient-centric. Home infusion therapy let patients reduce or even totally avoid outpatient hospital visits, and allows them to resume normal routines and work behaviors while still treating their illness. Home infusion therapy works closely with the patient to ensure that such services are appropriate and in the interest of the best patient care. Moreover, the outcome of home infusion therapy is reliable.  Favorable government policies and regulations, increasing geriatric population, rapid technological developments, and increasing adoption of home infusion therapies, are some of the key factors propelling market growth in the industry. High prevalence of chronic diseases such as HIV, cancer, diabetes is further expected to fuel market growth. Home infusion drugs are often not readily available through standard pharmacies and comparatively higher in cost. Most are obtained through hospital pharmacies, licensed home infusion agencies, or mail-order discount drug supply companies that can express deliver the drugs directly to the patient's home. However, increasing risk with patient's safety and occurrence of mistakes while using infusion devices and issues related to reimbursement policies for home infusion therapy are the major hindrance for market growth during the forecast period.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2250

The report provides comprehensive assessment of the market covering key elements such as revenue estimations, cost analysis, import/export, production and consumption trends, CAGR, gross margin, and supply & demand patterns. It also sheds light on recent technological developments, product advancements, and research and development activities in the region.

The report examines the key players operating in the market along with their market position, market share, revenue, gross margin, and business strategies. SWOT analysis and Porter’s Five Forces Analysis are used to examine and assess the market and its players. It also covers recent mergers and acquisitions, joint ventures, collaborations, agreements, partnerships, and product launches and brand promotions.

Key companies profiled in the report include:

Baxter, B. Braun Melsungen AG, ICU Medical Inc., Fresenius Kabi AG, Terumo Corporation, JMS Co. Ltd., CareFusion Corporation, Smiths Medical and Caesarea Medical Electronics.

Market Segmentation by Types:

Product (Revenue, USD Million; 2016–2026)

  • Infusion pumps
  • Intravenous sets
  • IV Cannulas
  • Needleless connectors

Market Segmentation by Applications:

Application (Revenue, USD Million; 2016–2026)

  • Anti- infective
  • Endocrinology
  • Hydration therapy
  • Chemotherapy
  • Enteral nutrition
  • Parenteral nutrition
  • Special pharmaceuticals

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2250

Regional analysis covers in-depth analysis of analysis of the revenue, market share, and growth rate of the global Home Infusion Therapy market in each region for the forecast period of 2021-2028. The report covers production and consumption rate, current and emerging trends, import/export, supply and demand, and presence of key players in each region.

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • Italy
    • France
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Rest of MEA

To know more about the report @ https://www.reportsanddata.com/report-detail/home-infusion-therapy-market

Further key findings from the report suggest

  • Home Infusion Therapy is growing at a CAGR of 3% in Asia Pacific followed by North America and Europe, with 7.2 % and 6.9% CAGR, respectively. High incidence of chronic diseases and availability of cost-effective home infusion therapies in developing and developed economies are expected to accelerate the market growth for home infusion therapy during forecast period across all regions
  • As of 2018, Anti-infective application segment is expected to dominate Home infusion therapy which holds the market share of 33.9% of the global market. North America region is the chief revenue generating source for this product segment, followed by Europe and Asia-Pacific regions
  • Chemotherapy is expected to be the fastest growing market segment during forecast period 2019-2026 with a CAGR of 7.7%. It is also the second largest segment in terms of revenue generation after anti-infective segment. For instance, according to the data of cancer organization, by January 1 2030, it is estimated that the population of cancer survivors will increase to more than 22.1 million due to the growth and aging of the population alone
  • Infusion pumps segment led the global infusion therapy market with a market share of 34.7% in 2018 and is forecasted to continue its dominance during the forecast period. Extensive application in delivering fluids containing nutrients and medications in controlled dosages is anticipated to fuel market growth
  • Needleless connectors segment is anticipated to witness lucrative growth with a CAGR of 7.9% registering fastest growth during the forecast period.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2250

Thank you for reading our report. For further inquiry, please connect with us and our team will make sure the report is customized according to your requirements.

Browse More Reports:

Atherectomy Market @ https://www.reportsanddata.com/report-detail/atherectomy-market

Coronary Stents Market @ https://www.reportsanddata.com/report-detail/coronary-stents-market

Medical Electronics Market @ https://www.reportsanddata.com/report-detail/medical-electronics-market

eClinical Solutions Market @ https://www.reportsanddata.com/report-detail/eclinical-solutions-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:                                        

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: [email protected]

 

 

 

collect
0
avatar
jhon tanison
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more